New biological treatments for psoriatic arthritis

Piercarlo Sarzi-Puttini, Fabiola Atzeni

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)643-645
Number of pages3
JournalIsrael Medical Association Journal
Volume16
Issue number10
Publication statusPublished - Oct 1 2014

Keywords

  • Apremilast
  • Interleukin 17 (Il-17) inhibitors
  • Psoriatic arthritis (PsA)
  • Rituximab
  • Tumor necrosis factor inhibitors (TNFi)
  • Ustekinumab

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sarzi-Puttini, P., & Atzeni, F. (2014). New biological treatments for psoriatic arthritis. Israel Medical Association Journal, 16(10), 643-645.

New biological treatments for psoriatic arthritis. / Sarzi-Puttini, Piercarlo; Atzeni, Fabiola.

In: Israel Medical Association Journal, Vol. 16, No. 10, 01.10.2014, p. 643-645.

Research output: Contribution to journalArticle

Sarzi-Puttini, P & Atzeni, F 2014, 'New biological treatments for psoriatic arthritis', Israel Medical Association Journal, vol. 16, no. 10, pp. 643-645.
Sarzi-Puttini P, Atzeni F. New biological treatments for psoriatic arthritis. Israel Medical Association Journal. 2014 Oct 1;16(10):643-645.
Sarzi-Puttini, Piercarlo ; Atzeni, Fabiola. / New biological treatments for psoriatic arthritis. In: Israel Medical Association Journal. 2014 ; Vol. 16, No. 10. pp. 643-645.
@article{edc0a3b2c48343f6b24f0118f61b6a36,
title = "New biological treatments for psoriatic arthritis",
keywords = "Apremilast, Interleukin 17 (Il-17) inhibitors, Psoriatic arthritis (PsA), Rituximab, Tumor necrosis factor inhibitors (TNFi), Ustekinumab",
author = "Piercarlo Sarzi-Puttini and Fabiola Atzeni",
year = "2014",
month = "10",
day = "1",
language = "English",
volume = "16",
pages = "643--645",
journal = "Israel Medical Association Journal",
issn = "1565-1088",
publisher = "Israel Medical Association",
number = "10",

}

TY - JOUR

T1 - New biological treatments for psoriatic arthritis

AU - Sarzi-Puttini, Piercarlo

AU - Atzeni, Fabiola

PY - 2014/10/1

Y1 - 2014/10/1

KW - Apremilast

KW - Interleukin 17 (Il-17) inhibitors

KW - Psoriatic arthritis (PsA)

KW - Rituximab

KW - Tumor necrosis factor inhibitors (TNFi)

KW - Ustekinumab

UR - http://www.scopus.com/inward/record.url?scp=84908220112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908220112&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 643

EP - 645

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

SN - 1565-1088

IS - 10

ER -